Home | Articles
Published on:March 2020
Indian Journal of Pharmaceutical Education and Research, 2020; 54(2):225-233
Review Article | doi:10.5530/ijper.54.2.27

Small Molecules Polypharmacology for the Treatment of Breast Cancer: A Roadmap for the Future Chemotherapy


Authors and affiliation (s):

Reetuparna Acharya, Shakti Prasad Pattanayak*

Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, INDIA.

Abstract:

Background: Breast cancer is considered as the most common ailment in women across the globe. There are a variety of major factors for the growth and progression of breast cancer. Although genetic changes are key factors for cancer progression, epigenetic and environmental factors also have their fair share of contribution. Hypothesis: An attempt has been made in the review to highlight about small molecule polypharmacology for the treatment of breast cancer which is the design of small molecules (molecular weight <900Da) that aim for two or more cancer targets (tyrosine kinases). Small molecules are advantageous over conventional chemotherapy with higher target specificity, lesser known side effects, simplified dosing schedule, non-invasive dosing and improved patient compliance. Results and Conclusion: Small molecules have been introduced since the past two decades and has been a potential success in the field of cancer chemotherapy, but there are lot more to explore. The review mainly focuses on the essential cellular signaling pathways involved in breast cancer progression and the recent small molecule inhibitors that show promising activity against the pathways.

Key words: Breast cancer, Small molecules, Polypharmacology, Tyrosine kinases, Chemotherapy.

 

Articles in PDF, ePUB and Full text are attached to this page. In order to download, print or access these formats you must be logged in.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
3 + 14 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).

 

Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
7 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs